Fusions of neurotrophic tropomyosin receptor kinase genes NTRK1, NTRK2 and NTRK3 with various partner genes have been detected in a variety of both common and rare tumour entities [1, 2]. This evidence concerns the gene NTRK1 and neoplasm.